<p>Urs Ochsner of SomaLogic, Inc. in the U.S. will lead a team to expand and test a library of SOMAmers (slow off-rate modified aptamers) to identify protein biomarkers that indicate active tuberculosis from a small sample of blood. SOMAmers, which are modified nucleic acid-based protein-binding agents, offer several advantages over the antibodies traditionally used in diagnostic tests including greater stability, lower cost, and no need for refrigeration.</p>


Urs Ochsner of SomaLogic, Inc. in the U.S. will lead a team to expand and test a library of SOMAmers (slow off-rate modified aptamers) to identify protein biomarkers that indicate active tuberculosis from a small sample of blood. SOMAmers, which are modified nucleic acid-based protein-binding agents, offer several advantages over the antibodies traditionally used in diagnostic tests including greater stability, lower cost, and no need for refrigeration.

SOMAmer-based Detection of Tuberculosis Biomarkers

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.